Showing results (381-390 of 477) with videos related to

Sort By:
Pageof 48
Journal of the American Heart Association|December 14, 2022
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 TrialShqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, et al.
Circulation. Arrhythmia and Electrophysiology|March 12, 2016
Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation CharacteristicsAmir S Jadidi, Heiko Lehrmann, Cornelius Keyl, et al.
European Heart Journal. Acute Cardiovascular Care|September 1, 2021
Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trialJ J Coughlan, Alp Aytekin, Gjin Ndrepepa, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
The Journal of Invasive Cardiology|June 5, 2021
Percutaneous Coronary Intervention vs Medical Therapy for Coronary Lesions With Positive Fractional Flow Reserve (FFR) but Preserved Pressure-Bounded Coronary Flow Reserve (CFR): A Substudy of the Randomized Compare-Acute TrialJoost D E Haeck, Marcel Van't Veer, Frederik M Zimmermann, et al.
Lancet (London, England)|July 30, 2013
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyGregg W Stone, Bernhard Witzenbichler, Giora Weisz, et al.
International Journal of Cardiology|June 14, 2021
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromesShqipdona Lahu, Gjin Ndrepepa, Senta Gewalt, et al.
European Heart Journal|May 15, 2020
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemicAlaide Chieffo, Giulio G Stefanini, Susanna Price, et al.
Circulation. Cardiovascular Interventions|May 24, 2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trialDominick J Angiolillo, Robert C Welsh, Dietmar Trenk, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2014
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trialKarl Fengler, Georg Fuernau, Steffen Desch, et al.
Pageof 48